Theranostics Health Announces the Appointment of Luis Gutierrez as President and CEO

Theranostics Health, Inc., a biotechnology company that develops and commercializes molecular diagnostic technologies to target therapies for optimal patient benefit, announced today the appointment of Luis T. Gutierrez, Jr. as President and Chief Executive Officer.  In that role, he will also join the company’s Board of Directors.  Glenn D. Hoke, PhD will remain with the company in the role of Executive Vice President and Chief Operating Officer.

TH Luis Gutierrez Press Release 10.27.2014